ContractAmendment • March 31st, 2003 • Depomed Inc • Pharmaceutical preparations
Amendment, dated as of September 30, 2002 (the “Amendment”), by and among DepoMed, Inc., a California corporation (the “Company”), Elan International Services, Ltd., a Bermuda exempted limited liability company (“EIS”), Elan Pharma International Limited, an Irish private limited liability company (“EPIL”), and Elan Corporation, plc, an Irish public limited company (“Elan”).
WAIVER AND TERMINATION AGREEMENT DATED 8 NOVEMBER, 2002 (THE “EFFECTIVE DATE”)Waiver and Termination Agreement • March 31st, 2003 • Depomed Inc • Pharmaceutical preparations
Whereas, Elan Corporation, plc, an Irish public limited company (“Elan”), DepoMed, Inc., a California corporation (the “Company”), Elan Pharma International Limited, a private limited company incorporated under the laws of Ireland (“EPIL”), and DepoMed Development Ltd., a Bermuda exempted limited liability company (“Newco”), entered into a License Agreement, dated January 21, 2000 (the “Elan License Agreement”), which set forth the terms and conditions of a license from Elan to Newco of certain intellectual property of Elan.
